Trending...
- Los Angeles County Now Distributing Vote by Mail Ballots to Registered Voters in Long Beach - 1224
- Afresh Enhances Supply Chain Capabilities with the Launch of Afresh DC Forecasts, Partnering with Albertsons Companies as the First Customer
- Nuvve Unveils Groundbreaking AC V2G Technology at Exelon Event, Leveraging SAE J3068/2
~ Specialty pharmaceutical company Dignify Therapeutics (Dignify) has been selected as a presenting company at the prestigious BIO Investor Forum in San Francisco. The event, which will take place at the Fairmount Hotel on October 16, 2024, provides a platform for emerging biotech companies to showcase their innovative products and engage with potential investors and partners.
Dignify is dedicated to restoring bowel and bladder function in patients with neurological diseases. Currently, many of these individuals rely on invasive and time-consuming methods such as bladder catheterization and manual bowel programs performed by caregivers. Dignify aims to revolutionize this treatment approach with their two drug programs.
The company's lead drug program, DTI-301, is a suppository that patients can use as needed for bowel evacuation. This medication has shown promising results, inducing defecation within 5-10 minutes with minimal absorption and systemic exposure. Dignify's second drug program, DTI-117, is currently in development for on-demand emptying of both the bladder and bowel. This small peptide directly stimulates smooth muscle contraction in these organs, producing voiding in less than 10 minutes.
More on The Californer
What sets Dignify's drugs apart is their quick action and minimal side effects. DTI-301 has a short plasma half-life and is rapidly eliminated from the body. The development of DTI-117 is also supported by funding from the National Institutes of Health (NIH).
According to Anthony DiTonno, CEO of Dignify Therapeutics, being selected as a presenting company at the BIO Investor Forum is an exciting opportunity for the company. It allows them to showcase their novel approach to treating severe unmet medical needs for patients in a multi-billion dollar market. DiTonno looks forward to engaging with institutional investors and strategic partners at the event as their two drug products approach clinical trials.
Dignify's innovative approach to treating bladder and bowel dysfunction has the potential to greatly improve the quality of life for patients with neurological diseases, diabetes, and the elderly. With their promising drug programs and support from the NIH, Dignify is poised to make a significant impact in this field.
Dignify is dedicated to restoring bowel and bladder function in patients with neurological diseases. Currently, many of these individuals rely on invasive and time-consuming methods such as bladder catheterization and manual bowel programs performed by caregivers. Dignify aims to revolutionize this treatment approach with their two drug programs.
The company's lead drug program, DTI-301, is a suppository that patients can use as needed for bowel evacuation. This medication has shown promising results, inducing defecation within 5-10 minutes with minimal absorption and systemic exposure. Dignify's second drug program, DTI-117, is currently in development for on-demand emptying of both the bladder and bowel. This small peptide directly stimulates smooth muscle contraction in these organs, producing voiding in less than 10 minutes.
More on The Californer
- Dark Truth Behind Targeted Violence
- Composer Andrew Prahlow to Perform Award-Winning Outer Wilds Soundtrack on Oct 17th at Brooklyn's Music Hall of Williamsburg
- All aboard! More clean buses and trains coming to California's communities most affected by pollution
- SolarTech Celebrates Grand Opening of Phoenix Facility with Ribbon Cutting Ceremony
- Are California Insurance Tax Hikes Good for Uninsurable Homes?
What sets Dignify's drugs apart is their quick action and minimal side effects. DTI-301 has a short plasma half-life and is rapidly eliminated from the body. The development of DTI-117 is also supported by funding from the National Institutes of Health (NIH).
According to Anthony DiTonno, CEO of Dignify Therapeutics, being selected as a presenting company at the BIO Investor Forum is an exciting opportunity for the company. It allows them to showcase their novel approach to treating severe unmet medical needs for patients in a multi-billion dollar market. DiTonno looks forward to engaging with institutional investors and strategic partners at the event as their two drug products approach clinical trials.
Dignify's innovative approach to treating bladder and bowel dysfunction has the potential to greatly improve the quality of life for patients with neurological diseases, diabetes, and the elderly. With their promising drug programs and support from the NIH, Dignify is poised to make a significant impact in this field.
Filed Under: Business
0 Comments
Latest on The Californer
- SlashNext Selected as Finalist in 2024 Top InfoSec Innovator Awards
- U.S. Fastener Import & Trading Co. Partners with Mizumoto Machine Mfg. Co., Ltd. for U.S. Expansion
- Blue Ridge Partners Hires Tech Leader Kyle Heller as Managing Director
- Shuddersome: Tales of Poe at Theatre School @ North Coast Rep
- UPDATED-Kadima Day School to Host October 7th Memorial Event in Remembrance and Reflection
- California deploys Urban Search and Rescue Task Force teams ahead of Hurricane Milton
- THINKWARE Announces Amazon Prime Big Deal Days Dash Cam Specials
- New Short-Term Care Insurance Has Some Attractive Features
- City Expands Local Preference Program for Procurements to Enhance Opportunities for Long Beach Businesses
- KENDALL-JACKSON OFFERS TRIP TO NBA ALL-STAR 2025 IN NATIONAL SWEEPSTAKES
- Hypothesis by Richard H. Davis: Carrier Pigeons and Milk Immunity
- VSA Officially Receives SOC 2 Approval
- Kadima Day School to Host October 7th Memorial Event in Remembrance and Reflection
- TVS Tavern TV Network on WatchYour.TV Goes Old School With Vintage Wrestling and Roller Derby
- California takes bold step to revolutionize youth sports with 25×25 Coaches Challenge
- Martial Arts Icon Cynthia Rothrock Premieres Her Latest Film Black Creek
- California: Governor Newsom statement marking one year since Hamas attack on Israel
- Vantiva and Harmonic Partner to Offer Service Providers Easy Transition from DOCSIS to Fiber-based PON Technologies
- CCHR Demands Justice for Victims of Psychiatric Fraud and Patient Sexual Abuse
- First World Chronic Cough Day October 15, 2024